Article Information
History
- May 1, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Rita Alkolla1,
- Alba Grifoni1,
- Shane Crotty1,2,3,
- Alessandro Sette1,2,
- Sara Gianella2 and
- Jennifer Dan1,2,*
- 1Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA
- 2Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, California, USA
- 3Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA, USA
- ↵*Corresponding author E-mail: jdan{at}health.ucsd.edu
Posted May 01, 2022.
Design and validation of HIV peptide pools for detection of HIV-specific CD4+ and CD8+ T cells
